Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Peginterferon Beta-1A (L03Ab13) Within The Framework Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99608061

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient peginterferon beta-1a (L03AB13) within the period from February 1, 2025 to January 31, 2027 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list according to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Peginterferon beta-1a (L03AB13) im Rahmen eine

Mt Ref Id - 99608061

Deadline - Nov 30, 2026